{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:34:35Z","timestamp":1777599275151,"version":"3.51.4"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Managing osteoporosis (OP) in chronic kidney disease (CKD) presents significant challenges due to altered bone metabolism. Given the lack of robust clinical trial data and a notable knowledge gap exists among nephrologists regarding an optimal management in this population, an expert consensus is crucial for developing tailored management strategies. This study aimed to gather an expert opinion to bridge this gap and establish consensus recommendations on the diagnosis and management of osteoporosis in CKD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A panel of 13 Indian and 1 international experts, including nephrologists and endocrinologists, participated in a structured survey and discussion process. Thirteen Indian experts provided their opinion on key clinical issues, including screening, diagnosis, and treatment strategies for osteoporosis in CKD. Consensus was achieved in a single round of voting, and recommendations were formulated based on the level of agreement among the panelists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The expert panel reached a strong consensus (80-100% agreement) on several critical recommendations. It was agreed that osteoporosis in CKD is often asymptomatic, with fragility fractures being less common, and thus, early screening using dual-energy X-ray absorptiometry (DXA) is essential. The panel emphasized the importance of evaluating bone turnover status using serum biomarkers such as bone-specific alkaline phosphatase (BSAP) and intact parathyroid hormone (iPTH) to guide treatment decisions. Tailored treatment strategies were recommended, with a judicious use of bisphosphonates and denosumab, depending on the patient\u2019s estimated glomerular filtration rate (eGFR) and bone turnover state. The management of renal osteodystrophy (ROD) was deemed necessary before addressing CKD-induced osteoporosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This expert consensus provides critical insights and guidance for the management of osteoporosis in CKD. The recommendations emphasize individualized treatment approaches, the importance of early screening, and the integration of multidisciplinary care. These findings aim to fill existing knowledge gaps and improve clinical outcomes for CKD patients with osteoporosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneph.2025.1601610","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T04:12:10Z","timestamp":1752120730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis, evaluation and management of osteoporosis in chronic kidney disease: navigating treatment approaches \u2013 Indian consensus statement"],"prefix":"10.3389","volume":"5","author":[{"given":"Vijay","family":"Kher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajkumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgi","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sishir","family":"Gang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatin","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kumar BT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh Kumar","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Om","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Bunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Nickolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"gfae069","DOI":"10.1093\/ndt\/gfae069.1570","article-title":"Prevalence of osteoporosis in dialysis dependent CKD patients: a cross sectional study from India","volume":"39","author":"Sharma","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.206439","article-title":"Prevalence of osteoporosis in patients with chronic kidney disease (stages 3-5) in comparison with age- and sex-matched controls: A study from Kashmir Valley Tertiary Care Center","volume":"28","author":"Najar","year":"2017","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1177829","article-title":"Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis","volume":"14","author":"Aguilar","year":"2023","journal-title":"Front Physiol"},{"key":"B4","unstructured":"Chronic kidney disease-mineral bone disorder (CKD-MBD)\n          \n          \n            \n              Shah\n              A\n            \n            \n              Hashmi\n              MF\n            \n            \n              Aeddula\n              NR\n            \n          \n          Treasure Island (FL\n          StatPearls Publishing\n          StatPearls\n          \n          2024"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186846","article-title":"Osteoporosis in patients with chronic kidney diseases: A systemic review","volume":"21","author":"Hsu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11031017","article-title":"Management of osteoporosis in CKD","volume":"13","author":"Khairallah","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41392-023-01467-8","article-title":"Targeting strategies for bone diseases: signaling pathways and clinical studies","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1590\/1516-3180.2022.0043.R1.07042022","article-title":"Assessment of the strength of recommendation and quality of evidence: GRADE checklist. A descriptive study","volume":"140","author":"Bezerra","year":"2022","journal-title":"Sao Paulo Med J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2015195","article-title":"Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes","volume":"57","author":"Chuang","year":"2016","journal-title":"Singapore Med J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/life14030418","article-title":"Chronic kidney disease with mineral bone disorder and vascular calcification: an overview","volume":"14","author":"Izzo","year":"2024","journal-title":"Life (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.183457","article-title":"Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India","volume":"20","author":"Vikrant","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5049\/EBP.2014.12.2.35","article-title":"Gaps between global guidelines and local practices in CKD-MBD","volume":"12","author":"Kim","year":"2014","journal-title":"Electrolyte Blood Press"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8618-16","article-title":"Management of osteoporosis in chronic kidney disease","volume":"56","author":"Nitta","year":"2017","journal-title":"Intern Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-23-435","article-title":"Expert consensus-promoting clinical excellence and ultimately benefitting patients","volume":"12","author":"Chen","year":"2023","journal-title":"Hepatobil Surg Nutr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006732.pub4","article-title":"Interventions for increasing the use of shared decision making by healthcare professionals","volume":"7","author":"L\u00e9gar\u00e9","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1159\/000526492","article-title":"Consensus evidence-based clinical practice recommendations for the diagnosis and treat-to-target management of osteoporosis in chronic kidney disease stages G4-G5D and post-transplantation: an initiative of Egyptian academy of bone health","volume":"8","author":"El Miedany","year":"2022","journal-title":"Kidney Dis (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/152715440000100409","article-title":"Building consensus using the policy delphi method","volume":"1","author":"Rayens","year":"2000","journal-title":"Policy Politics Nurs Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.IJN_1_20","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention and prevention of chronic kidney disease-mineral and bone disorder (CKD-MBD): Indian commentary","volume":"30","author":"Valson","year":"2020","journal-title":"Indian J Nephrol"},{"key":"B20","unstructured":"Chronic kidney disease\n          \n          \n            \n              Vaidya\n              SR\n            \n            \n              Aeddula\n              NR\n            \n          \n          Treasure Island (FL\n          StatPearls Publishing\n          StatPearls\n          \n          2024"},{"key":"B21","unstructured":"An overview of glucocorticoid-induced osteoporosis\n          \n          \n            \n              Ilias\n              I\n            \n            \n              Milionis\n              C\n            \n            \n              Zoumakis\n              E\n            \n          \n          \n            \n              Feingold\n              KR\n            \n            \n              Anawalt\n              B\n            \n            \n              Blackman\n              MR\n            \n          \n          25905202\n          South Dartmouth (MA)\n          MDText.com, Inc.\n          Endotext\n          \n          2022"},{"key":"B22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-JBN-2021-S103","article-title":"Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)","volume":"43","author":"Bucharles","year":"2021","journal-title":"J Bras Nefrol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.06.031","article-title":"Diagnosis and management of osteoporosis in advanced kidney disease: A review","volume":"79","author":"Ginsberg","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.09.022","article-title":"The Fracture Risk Assessment Tool (FRAX\u00ae) predicts fracture risk in patients with chronic kidney disease","volume":"95","author":"Whitlock","year":"2019","journal-title":"Kidney Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.2471\/BLT.16.188532","article-title":"Clarifying WHO\u2019s position on the FRAX\u00ae tool for fracture prediction","volume":"94","author":"Ford","year":"2016","journal-title":"Bull World Health Organ"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S120175","article-title":"Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study","volume":"11","author":"Nishikawa","year":"2016","journal-title":"Clin Interv Aging"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S426869","article-title":"Denosumab use in chronic kidney disease associated osteoporosis: A narrative review","volume":"16","author":"Abduelkarem","year":"2023","journal-title":"Risk Manag Healthc Policy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1210\/clinem\/dgaa851","article-title":"Denosumab safety and efficacy among participants in the FREEDOM extension study with mild to moderate chronic kidney disease","volume":"106","author":"Broadwell","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1601610\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T04:12:12Z","timestamp":1752120732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1601610\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":29,"alternative-id":["10.3389\/fneph.2025.1601610"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2025.1601610","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"article-number":"1601610"}}